Europe News: NEW DELHI: Several countries have suspended or delayed the rollout of the Covid-19 vaccine developed by Oxford University-AstraZeneca following report.
AstraZeneca has said the vaccine has been studied extensively during Phase 3 trials and peer-reviewed data confirms the shot is “generally well tolerated.”
Pfizer vaccine provides less protection in cancer patients after a single dose, study finds waaytv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from waaytv.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca has said the vaccine has been studied extensively during Phase 3 trials and peer-reviewed data confirms the shot is "generally well tolerated."
Health authorities in Denmark, Norway and Iceland on Thursday (March 11) suspended the use of AstraZeneca’s Covid-19 vaccine following reports of the formation of blood clots in some people who had been vaccinated. Austria earlier stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism. Still, the European medicine.